MX2009011407A - Antagonistas crig. - Google Patents
Antagonistas crig.Info
- Publication number
- MX2009011407A MX2009011407A MX2009011407A MX2009011407A MX2009011407A MX 2009011407 A MX2009011407 A MX 2009011407A MX 2009011407 A MX2009011407 A MX 2009011407A MX 2009011407 A MX2009011407 A MX 2009011407A MX 2009011407 A MX2009011407 A MX 2009011407A
- Authority
- MX
- Mexico
- Prior art keywords
- crig
- antagonists
- erythrocytes
- parasites
- platelets
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Abstract
La presente invención se refiere a anticuerpos de bloqueo que se enlazan específicamente a un receptor especifico de un macrófago recientemente descubierto, CRIg, y su uso para prevenir la entrada celular de patógenos intracelulares, como los virus, bacterias o parásitos; así como para la prevención de la depuración no deseada de eritrocitos y plaquetas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91534007P | 2007-05-01 | 2007-05-01 | |
PCT/US2008/061513 WO2008137338A1 (en) | 2007-05-01 | 2008-04-25 | CRIg ANTAGONISTS |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009011407A true MX2009011407A (es) | 2009-11-05 |
Family
ID=39645433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009011407A MX2009011407A (es) | 2007-05-01 | 2008-04-25 | Antagonistas crig. |
Country Status (16)
Country | Link |
---|---|
US (1) | US20090162356A1 (es) |
EP (1) | EP2152749A1 (es) |
JP (1) | JP2010526076A (es) |
KR (1) | KR20100018523A (es) |
CN (1) | CN101675078A (es) |
AR (1) | AR066375A1 (es) |
AU (1) | AU2008247958A1 (es) |
BR (1) | BRPI0810926A2 (es) |
CA (1) | CA2682835A1 (es) |
CL (1) | CL2008001238A1 (es) |
IL (1) | IL201165A0 (es) |
MX (1) | MX2009011407A (es) |
PE (1) | PE20090239A1 (es) |
RU (1) | RU2009144280A (es) |
WO (1) | WO2008137338A1 (es) |
ZA (1) | ZA200906812B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
RU2553517C2 (ru) | 2008-05-06 | 2015-06-20 | Дженентек, Инк. | Варианты crig с созревшей аффинностью |
US8241623B1 (en) | 2009-02-09 | 2012-08-14 | David Bermudes | Protease sensitivity expression system |
US8771669B1 (en) | 2010-02-09 | 2014-07-08 | David Gordon Bermudes | Immunization and/or treatment of parasites and infectious agents by live bacteria |
US9597379B1 (en) | 2010-02-09 | 2017-03-21 | David Gordon Bermudes | Protease inhibitor combination with therapeutic proteins including antibodies |
US8524220B1 (en) | 2010-02-09 | 2013-09-03 | David Gordon Bermudes | Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
US9593339B1 (en) | 2013-02-14 | 2017-03-14 | David Gordon Bermudes | Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment |
CN104231085B (zh) * | 2013-09-05 | 2017-03-15 | 复旦大学附属肿瘤医院 | 靶向特异性补体系统抑制剂、其制备方法及应用 |
CN105924515B (zh) * | 2016-04-25 | 2019-06-14 | 中国人民解放军第三军医大学 | 免疫共刺激分子vsig4激活性表位肽、单克隆抗体及其制备方法和应用 |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
CN110944666A (zh) | 2017-06-26 | 2020-03-31 | 博奥泰克尼公司 | 杂交瘤克隆、vsig-4的单克隆抗体,以及制备和使用的方法 |
EP3873929A4 (en) * | 2018-09-28 | 2022-11-23 | Eutilex Co., Ltd. | ANTI-HUMAN VSIG4 ANTIBODIES AND USES THEREOF |
US20220233756A1 (en) * | 2019-05-17 | 2022-07-28 | George A. Herzlinger | Methods and systems for treating microbial disease |
EP4025606A1 (en) * | 2019-09-04 | 2022-07-13 | Y-Biologics Inc. | Anti-vsig4 antibody or antigen binding fragment and uses thereof |
EP4301786A1 (en) | 2021-03-03 | 2024-01-10 | Pierre Fabre Medicament | Anti-vsig4 antibody or antigen binding fragment and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8088386B2 (en) * | 1998-03-20 | 2012-01-03 | Genentech, Inc. | Treatment of complement-associated disorders |
-
2008
- 2008-04-25 RU RU2009144280/10A patent/RU2009144280A/ru not_active Application Discontinuation
- 2008-04-25 EP EP08769166A patent/EP2152749A1/en not_active Withdrawn
- 2008-04-25 MX MX2009011407A patent/MX2009011407A/es active IP Right Grant
- 2008-04-25 JP JP2010506507A patent/JP2010526076A/ja active Pending
- 2008-04-25 BR BRPI0810926-5A2A patent/BRPI0810926A2/pt not_active IP Right Cessation
- 2008-04-25 CA CA002682835A patent/CA2682835A1/en not_active Abandoned
- 2008-04-25 WO PCT/US2008/061513 patent/WO2008137338A1/en active Application Filing
- 2008-04-25 KR KR1020097024920A patent/KR20100018523A/ko not_active Application Discontinuation
- 2008-04-25 CN CN200880014866A patent/CN101675078A/zh active Pending
- 2008-04-25 AU AU2008247958A patent/AU2008247958A1/en not_active Abandoned
- 2008-04-25 US US12/150,220 patent/US20090162356A1/en not_active Abandoned
- 2008-04-30 AR ARP080101847A patent/AR066375A1/es not_active Application Discontinuation
- 2008-04-30 CL CL2008001238A patent/CL2008001238A1/es unknown
- 2008-04-30 PE PE2008000774A patent/PE20090239A1/es not_active Application Discontinuation
-
2009
- 2009-09-24 IL IL201165A patent/IL201165A0/en unknown
- 2009-09-30 ZA ZA2009/06812A patent/ZA200906812B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2152749A1 (en) | 2010-02-17 |
PE20090239A1 (es) | 2009-03-19 |
CN101675078A (zh) | 2010-03-17 |
BRPI0810926A2 (pt) | 2014-11-04 |
RU2009144280A (ru) | 2011-06-10 |
IL201165A0 (en) | 2010-05-17 |
JP2010526076A (ja) | 2010-07-29 |
WO2008137338A1 (en) | 2008-11-13 |
AU2008247958A1 (en) | 2008-11-13 |
CA2682835A1 (en) | 2008-11-13 |
US20090162356A1 (en) | 2009-06-25 |
KR20100018523A (ko) | 2010-02-17 |
ZA200906812B (en) | 2010-12-29 |
CL2008001238A1 (es) | 2008-11-07 |
AR066375A1 (es) | 2009-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009011407A (es) | Antagonistas crig. | |
PH12015500248A1 (en) | Humanized anti-cxcr5 antibodies, derivatives thereof and their uses | |
ATE488232T1 (de) | P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen | |
TN2010000213A1 (en) | Wise binding antibodies and epitopes | |
MY152503A (en) | 4-phenyl-pyrane-3, 5-diones, 4-phenyl-thiopyrane-3, 5-diones and cyclohexanetriones as novel herbicides | |
GB2453058A (en) | Kinase antagonists | |
MY155621A (en) | Axl antibodies | |
UA101478C2 (ru) | Соединения, полезные как ингибиторы raf-киназы | |
IL212100A0 (en) | Cross-species-specific spcaxcd3, cd19xcd3, c-metxcd3, endosialinxcd3, epcamxcd3, igf-irxcd3 or fapalphaxcd3 bispecific single chain antibodies, compositions comprising the same and uses thereof | |
MX2009008347A (es) | Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso. | |
MX354099B (es) | Antagonistas de activina-actriia y usos para tratar o prevenir cancer de mama. | |
UA100874C2 (en) | Bivalent bispecific antibodies | |
MX2010006396A (es) | Anticuerpos bivalentes, biespecificos. | |
MX2010005888A (es) | Anticuerpos bivalentes biespecificos. | |
MX2012001156A (es) | Moleculas que contienen boro trisustituidas. | |
WO2008097439A3 (en) | Anti-autoimmune antibodies for treatment of pemphigus | |
EA200971068A1 (ru) | Триазолиламинопиримидиновые соединения | |
MX343930B (es) | Nuevas composiciones y metodos para controlar los nematodos plaga. | |
EA201000258A1 (ru) | Новые гербициды | |
EA201170483A1 (ru) | Твердая фармацевтическая композиция | |
MX2014005765A (es) | Compuestos triciclicos, composiciones que los comprenden y usos de los mismos. | |
PL1987357T3 (pl) | Polipeptydy rozpoznawane przez przeciwciała anty-Trichinella oraz ich zastosowanie | |
MX2011013351A (es) | Materiales de soporte inorgánicos que contienen compuestos de 3 anillos heterocíclicos. | |
WO2012080641A8 (fr) | Agonistes des recepteurs s1p et leur utilisation dans le traitement des infections du vih | |
EP2576575A4 (en) | PROSTAGLANDIN-BISPHOSPHONATE CONJUGATE COMPOUNDS, THEIR METHODS OF MANUFACTURE AND USES THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HH | Correction or change in general | ||
FG | Grant or registration |